Goldman Sachs Group Inc Alkermes Plc. Transaction History

Goldman Sachs Group Inc

$613 Billion
Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,442,796 shares of ALKS stock, worth $49.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,442,796

Previous 1,746,157 17.37%

Holding current value

$49.4 Million

Previous $48.9 Million 15.1%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$25.7 - $31.46 $7.8 Million - $9.54 Million	-303,361 Reduced 17.37%	1,442,796 $41.5 Million
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $11.7 Million - $14.5 Million	507,981 Added 41.03%	1,746,157 $48.9 Million
Q2 2024 Aug 13, 2024	SELL	$23.21 - $27.24 $3.42 Million - $4.01 Million	-147,171 Reduced 10.62%	1,238,176 $29.8 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $461,260 - $568,888	-17,472 Reduced 1.25%	1,385,347 $37.5 Million
Q4 2023 Feb 13, 2024	SELL	$23.37 - $28.68 $12.2 Million - $15 Million	-523,805 Reduced 27.19%	1,402,819 $38.9 Million
Q3 2023 May 14, 2024	BUY	$27.17 - $31.97 $14.2 Million - $16.7 Million	523,805 Added 37.34%	1,926,624 $54 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $7.68 Million - $9.04 Million	282,660 Added 17.19%	1,926,624 $54 Million
Q2 2023 May 14, 2024	BUY	$28.34 - $33.63 $8.58 Million - $10.2 Million	302,696 Added 22.57%	1,643,964 $51.5 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $8.58 Million - $10.2 Million	302,696 Added 22.57%	1,643,964 $51.5 Million
Q1 2023 May 14, 2024	SELL	$25.31 - $29.02 $13.3 Million - $15.2 Million	-524,639 Reduced 28.12%	1,341,268 $37.8 Million
Q1 2023 May 11, 2023	SELL	$25.31 - $29.02 $13.3 Million - $15.2 Million	-524,639 Reduced 28.12%	1,341,268 $37.8 Million
Q4 2022 May 14, 2024	SELL	$21.94 - $26.24 $5.23 Million - $6.26 Million	-238,566 Reduced 11.34%	1,865,907 $48.8 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $5.23 Million - $6.26 Million	-238,566 Reduced 11.34%	1,865,907 $48.8 Million
Q3 2022 May 14, 2024	SELL	$22.0 - $31.87 $3.95 Million - $5.72 Million	-179,325 Reduced 7.85%	2,104,473 $47 Million
Q3 2022 Nov 10, 2022	SELL	$22.0 - $31.87 $3.95 Million - $5.72 Million	-179,325 Reduced 7.85%	2,104,473 $47 Million
Q2 2022 May 14, 2024	BUY	$26.4 - $30.54 $23.3 Million - $26.9 Million	880,979 Added 62.8%	2,283,798 $68 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $33,871 - $39,182	-1,283 Reduced 0.06%	2,283,798 $68 Million
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $7.29 Million - $8.85 Million	316,115 Added 16.05%	2,285,081 $60.1 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $1.62 Million - $2.42 Million	75,453 Added 3.98%	1,968,966 $45.8 Million
Q3 2021 Nov 10, 2021	BUY	$23.37 - $32.13 $44.3 Million - $60.8 Million	1,893,513 New	1,893,513 $58.4 Million

Others Institutions Holding ALKS

# of Institutions

376

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Alkermes Plc. Transaction History